» Articles » PMID: 35957941

Nerve Growth Factor and S100B: Molecular Marker of Neuroregeneration After Injection of Freeze-Dried Platelet Rich Plasma

Overview
Publisher Elsevier
Date 2022 Aug 12
PMID 35957941
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Chronic orofacial pain is associated with nerve tissues damage. Pharmacological therapy has limited therapeutic results because it is generally only symptomatic treatment. Neuroregeneration is a process which is needed to repair damaged of nerve tissue through healing or regrowth of nerve tissue. The survival of nerve cells need neurotrophic factors including Nerve Growth Factor (NGF) and S100B. High platelet concentrations in Platelet Rich Plasma contain of many trophic factors which play an important role in peripheral nerve regeneration following nerve injury. The aim of the present study is to analyze the increased expression of NGF and S100B following injection of Freeze-Dried Platelet Rich Plasma (FD-PRP) on axonotmesis injury.

Methods: Fifty-four male wistar rats aged 3 months randomly divided into 3 groups; negative control group (without nerve injury and without FD-PRP injection), positive control group (nerve injury but without FD-PRP injection) and treatment group (nerve injury and FD-PRP injection). Axonotmesis nerve injury created by clamping the infraorbital nerve for 15 s. Application of FD-PRP by injection technique. Examination of NGF and S100B expression was obtained by immunohistochemistry examination with monoclonal antibodies (anti-NGF and anti-S100B). Samples were taken on the 14th day and 21st day.

Results: Treatment group showed significant increase on both NGF and S100B compare to positive control (p = 0,000 and p = 0,000, respectively).

Conclusion: FD-PRP injection is effective in inducing neuroregeneration by increasing NGF and S100B expression.

Citing Articles

Targeting nerve growth factor for pain relief: pros and cons.

Jaffal S, Khalil R Korean J Pain. 2024; 37(4):288-298.

PMID: 39322310 PMC: 11450303. DOI: 10.3344/kjp.24235.


Role of Neurotrophins in Orofacial Pain Modulation: A Review of the Latest Discoveries.

Bonomini F, Favero G, Castrezzati S, Borsani E Int J Mol Sci. 2023; 24(15).

PMID: 37569811 PMC: 10419393. DOI: 10.3390/ijms241512438.


Role of transforming growth factor-β in peripheral nerve regeneration.

Ding Z, Jiang M, Qian J, Gu D, Bai H, Cai M Neural Regen Res. 2023; 19(2):380-386.

PMID: 37488894 PMC: 10503632. DOI: 10.4103/1673-5374.377588.

References
1.
Bauder A, Ferguson T . Reproducible mouse sciatic nerve crush and subsequent assessment of regeneration by whole mount muscle analysis. J Vis Exp. 2012; (60). PMC: 3376939. DOI: 10.3791/3606. View

2.
Fujiwara S, Hoshikawa S, Ueno T, Hirata M, Saito T, Ikeda T . SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination. PLoS One. 2014; 9(12):e115400. PMC: 4275212. DOI: 10.1371/journal.pone.0115400. View

3.
Ma S, Peng C, Wu S, Wu D, Gao C . Sciatic nerve regeneration using a nerve growth factor-containing fibrin glue membrane. Neural Regen Res. 2014; 8(36):3416-22. PMC: 4146009. DOI: 10.3969/j.issn.1673-5374.2013.36.007. View

4.
Zhang N, Wu Y, Qian S, Teng C, Chen S, Li H . Research progress in the mechanism of effect of PRP in bone deficiency healing. ScientificWorldJournal. 2013; 2013:134582. PMC: 3654280. DOI: 10.1155/2013/134582. View

5.
Dubovy P . Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann Anat. 2011; 193(4):267-75. DOI: 10.1016/j.aanat.2011.02.011. View